Have a personal or library account? Click to login
HBV genotypes circulation in pregnant women in Romania: a pilot study Cover

HBV genotypes circulation in pregnant women in Romania: a pilot study

Open Access
|Feb 2020

References

  1. 1. WHO Regional Committee for Europe, Action plan for the health sector response to viral hepatitis in the WHO European Region, WHO Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark, 2017, viii + 44 pages.
  2. 2. IARC Working Group, HEPATITIS B VIRUS, International Agency for Research on Cancer, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 150 cours Albert Thomas, 69372 Lyon Cedex 08, France, 2012;100(Pt B):1-441.
  3. 3. Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-98. DOI: 10.1016/j.jhep.2017.03.02110.1016/j.jhep.2017.03.02128427875
  4. 4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. DOI: 10.3322/caac.2149210.3322/caac.2149230207593
  5. 5. Popovici O, Radu R, Romaniuc A, Azoicăi D. A sero-prevalence study for hepatitis B virus markers of infection in pregnant women in Romania: results and opportunities for prevention. J Gastrointestin Liver Dis. 2018 Jun;27(2):133-7. DOI: 10.15403/jgld.2014.1121.272. hpb10.15403/jgld.2014.1121.272
  6. 6. Popovici O, Molnar GB, Popovici F, Janţă D, Pistol A, Azoicăi D. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy. J Gastrointestin Liver Dis. 2016 Mar;25(1):25-32. DOI: 10.15403/jgld.2014.1121.251. hbc10.15403/jgld.2014.1121.251
  7. 7. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-4. DOI: 10.1002/cld.72810.1002/cld.728638589930988907
  8. 8. Ursu RG, Luca CM, Luca AS, Toader E, Simion L, Iancu LS. Laboratory diagnosis for optimize therapy of B hepatitis virus infection by using biochemical and molecular biology methods. Rev. Chim. (Bucharest), 2016; 67(12): 2614-261.
  9. 9. Luca AS, Luca MC, Ursu RG, Iancu LS. The Study of VHB genotypes in a population - a pilot study. Rev. Chim. (Bucharest), 2016; 67(3): 500-2.
  10. 10. Constantinescu I, Nedelcu F, Toader MA, Daniela V. Clinical and therapeutical importance of HBV genotyping in Romania. J Med Life. 2008 Apr-Jun;1(2):165-73.
  11. 11. Constantinescu I, Dinu AA, Boscaiu V, Niculescu M. Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, Romania. Hepat Mon. 2014 Oct 20;14(10):e22072. DOI: 10.5812/hepatmon.2207210.5812/hepatmon.22072425096625477976
  12. 12. Kmet Lunaček N, Poljak M, Matičič M. Distribution of hepatitis B virus genotypes in Europe and clinical implications: a review. Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):141-6. DOI: 10.15570/actaapa.2018.2810.15570/actaapa.2018.28
  13. 13. Toy M, Veldhuijzen IK, Mostert MC, de Man RA, Richardus JH. Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands. J Med Virol. 2008 Mar;80(3):399-404. DOI: 10.1002/jmv.2109810.1002/jmv.2109818205235
  14. 14. Moussa S, Brah S, Parola P, Gerolami R, Gamerre M, Boubli L, et al. Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France. J Med Virol. 2016 May;88(5):828-36. DOI: 10.1002/jmv.2439810.1002/jmv.2439826439319
  15. 15. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92.
  16. 16. Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):249-55. DOI: 10.1016/j.bpg.2017.04.01010.1016/j.bpg.2017.04.01028774406
  17. 17. Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol. 2014 Jun 21;20(23):7152-68. DOI: 10.3748/wjg.v20.i23.715210.3748/wjg.v20.i23.7152406406124966586
  18. 18. Rajoriya N, Combet C, Zoulim F, Janssen HLA. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J Hepatol. 2017 Dec;67(6):1281-97. DOI: 10.1016/j.jhep.2017.07.01110.1016/j.jhep.2017.07.01128736138
  19. 19. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014 May 14;20(18):5427-34. DOI: 10.3748/wjg.v20. i18.542710.3748/wjg.v20.i18.5427
  20. 20. Velkov S, Ott JJ, Protzer U, Michler T. The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. Genes (Basel). 2018 Oct 15;9(10). DOI: 10.3390/genes910049510.3390/genes9100495621029130326600
  21. 21. Lampe E, Mello FCA, do Espírito-Santo MP, Oliveira CMC, Bertolini DA, Gonçales NSL, et al. Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study. J Gen Virol. 2017 Jun;98(6):1389-98. DOI: 10.1099/jgv.0.00078910.1099/jgv.0.000789596289628631602
  22. 22. Marciano S, Galdame OA, Gadano AC. HBV genotype F: natural history and treatment. Antivir Ther. 2013;18(3 Pt B):485-8. DOI: 10.3851/IMP260410.3851/IMP260423792712
  23. 23. Hirzel C, Wandeler G, Owczarek M, Gorgievski-Hrisoho M, Dufour JF, Semmo N, et al. Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study. BMC Infect Dis. 2015 Oct 30;15:483. DOI: 10.1186/s12879-015-1234-z10.1186/s12879-015-1234-z462834426518625
  24. 24. Michitaka K, Hiraoka A, Imai Y, Utsunomiya H, Tatsukawa H, Shimizu Y, et al. Clinical features and hepatitis B virus (HBV) genotypes in pregnant women chronically infected with HBV. Intern Med. 2012;51(24):3317-22. DOI: 10.2169/internalmedicine.51.859610.2169/internalmedicine.51.859623257514
  25. 25. Ding Y, Sheng Q, Ma L, Dou X. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J. 2013 Jan 7;10:17. DOI: 10.1186/1743-422X-10-1710.1186/1743-422X-10-17356801123294983
  26. 26. Harder KM, Cowan S, Eriksen MB, Krarup HB, Christensen PB. Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark. Vaccine. 2011 Nov 21;29(50):9303-7. DOI: 10.1016/j.vaccine.2011.10.02810.1016/j.vaccine.2011.10.02822019756
  27. 27. Dervisevic S, Ijaz S, Chaudry S, Tedder RS. Non-A hepatitis B virus genotypes in antenatal clinics, United Kingdom. Emerg Infect Dis. 2007 Nov;13(11):1689-93. DOI: 10.3201/eid1311.07057810.3201/eid1311.070578337577818217552
  28. 28. Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, et al. Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns. Liver Int. 2015 Feb;35(2):409-16. DOI: 10.1111/liv.1256110.1111/liv.1256124698736
  29. 29. Faleye TO, Adewumi MO, Ifeorah IM, Omoruyi EC, Bakarey SA, Akere A, et al. Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria. Springerplus. 2015 Feb 1;4:43. DOI: 10.1186/s40064-015-0813-110.1186/s40064-015-0813-1432014125674500
  30. 30. Baclig MO, Reyes KG, Liles VR, Gopez-Cervantes J. Untypable genotype restriction patterns and surface gene variants of hepatitis B virus isolates. Int J Mol Epidemiol Genet. 2017 Jun 20;8(3):19-26.
  31. 31. Pettersson JH, Myking S, Elshaug H, Bygdås KIE, Stene-Johansen K. Molecular epidemiology of hepatitis B virus infection in Norway. BMC Infect Dis. 2019 Mar 7;19(1):236. DOI: 10.1186/s12879-019-3868-810.1186/s12879-019-3868-8640726730845915
  32. 32. Alidjinou EK, Bocket L, Pigot V, Lambert V, Hallaert C, Canva V, et al. Sanger sequencing versus INNO-Li-PA® HBV PreCore assay for routine detection of pre-core and basal core promoter mutations in hepatitis virus B chronically infected patients. Diagn Microbiol Infect Dis. 2018 Apr;90(4):277-279. DOI: 10.1016/j.diagmicrobio.2017.12.00610.1016/j.diagmicrobio.2017.12.00629310947
  33. 33. Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW et al. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology. 2014 Apr;146(4):980-8. DOI: 10.1053/j.gastro.2013.12.02810.1053/j.gastro.2013.12.02824368224
  34. 34. Chevaliez S, Dauvillier C, Dubernet F, Poveda JD, Laperche S, Hézode C, et al. The New Aptima HBV Quant Real-Time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F. J Clin Microbiol. 2017 Apr;55(4):1211-9. DOI: 10.1128/JCM.02219-1610.1128/JCM.02219-16537784928202793
DOI: https://doi.org/10.2478/rrlm-2020-0010 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 91 - 98
Submitted on: Oct 11, 2019
|
Accepted on: Jan 12, 2020
|
Published on: Feb 7, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Odette Popovici, Ramona Gabriela Ursu, Doina Azoicai, Luminita Smaranda Iancu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.